N NOS [aapp, imft]
Novel [tmco]
Merged [acty]
Scaffold [mnob]
Orally [spco]
Available [ftcn]
Dual [inpr]
soluble [celc]
Epoxide hydrolase [aapp, enzy]
peroxisome proliferator activated receptor [aapp, rcpt]
Gamma [npop]
Modulator [mnob]
Metabolic syndrome [dsyn]
Multifactorial [fndg]
Disease [dsyn]
Cluster [idcn]
Dyslipidaemia [dsyn]
Cardiovascular disease [dsyn]
Obesity [dsyn]
Metabolic syndrome [dsyn]
Patients [podg]
Exposed [clna]
Polypharmacy [fndg]
Pharmacological [bmod]
Compound [qlco]
Required [ftcn]
Metabolic syndrome [dsyn]
treatment [ftcn]
Reduced [qlco]
Application [hlca]
Compound [qlco]
This [euka]
Study [mnob]
Design [acty]
Dual [inpr]
Target [ftcn]
Ligands [chem]
Target [ftcn]
soluble [celc]
Epoxide hydrolase [aapp, enzy]
Peroxisome Proliferator-Activated Receptor gamma [aapp, rcpt]
Type [qlco]
Simultaneous [tmco]
Modulation [spco]
soluble [celc]
Epoxide hydrolase [aapp, enzy]
Peroxisome Proliferator-Activated Receptor gamma [aapp, rcpt]
Type [qlco]
diabetic [fndg]
condition [dsyn]
Hypertension [dsyn]
N NOS [aapp, imft]
derivatives [chvs]
To [qlco]
Fit [sosy]
Merged [acty]
soluble [celc]
Epoxide hydrolase [aapp, enzy]
Peroxisome Proliferator-Activated Receptor gamma [aapp, rcpt]
Type [qlco]
pharmacophore [rcpt]
Structure-Activity Relationship [qlco]
Study [mnob]
Performed [ftcn]
Target [ftcn]
soluble [celc]
Epoxide hydrolase [aapp, enzy]
Mu [inpr]
M NOS [aapp, imft]
Peroxisome Proliferator-Activated Receptor gamma [aapp, rcpt]
Type [qlco]
Mu [inpr]
M NOS [aapp, imft]
Modulator [mnob]
In Vitro [inpr]
In Vivo [spco]
Evaluations [ftcn]
Revealed [qlco]
Good [qlco]
properties [qlco]
Qualifying [qlco]
Pharmacological [bmod]
Tool [mnob]
Compound [qlco]
Long-term [tmco]
Models, Animal [anim]
Metabolic syndrome [dsyn]
